AU Stock MarketDetailed Quotes
CYP Cynata Therapeutics Ltd
- 0.185
- +0.005+2.78%
20min DelayMarket Closed Dec 16 16:00 AET
33.45MMarket Cap-3.43P/E (Static)
0.185High0.170Low655.95KVolume0.185Open0.180Pre Close118.16KTurnover0.34552wk High0.50%Turnover Ratio180.80MShares0.12052wk Low-0.054EPS TTM24.25MFloat Cap0.640Historical HighLossP/E (Static)131.05MShs Float0.105Historical Low-0.054EPS LYR8.33%Amplitude--Dividend TTM4.63P/B1Lot Size--Div YieldTTM
About Cynata Therapeutics Ltd Company
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.
Company Profile
SymbolCYP
Company NameCynata Therapeutics Ltd
Founded2003
MarketASX
Employees2
Fiscal Year Ends06-30
Address100 Cubitt Street Level 3
CityCremorne
CountryAustralia
Zip Code3121
Phone+61 370676940
Websitehttps://www.cynata.com
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Kilian Kelly
- Chief Executive Officer,Managing Director
- --
- Geoffrey E.D Brooke
- Non-Executive Director,Non-Executive Chairman
- --
- Paul K Wotton
- Non-Executive Director
- --
- Janine Rolfe
- Non-Executive Director
- --
- Darryl Maher
- Non-Executive Director
- --
Heat List
AU
Overall
Symbol
Price
% Chg
No Data